Antioxidant treatment inhibited glutamate-evoked NF-kappa B activation in primary astroglial cell cultures

n glial cells, glutamate exposure causes alterations in cell redox status, mainly mediated by glutathione depletion and reactive oxygen species generation. These effects finally lead to astrocyte dysfunction which contributes to the pathogenesis of several neurological disorders. This study was aimed to investigate the involvement of the NF-kappa B pathway in oxidative stress induced by glutamate exposure in primary cultures of astrocytes. Further we evaluated the power of the antioxidants genistein (0.1-10 mu M) and IRFI 016 (20-80 mu M), a synthetic tocopherol analogue, compared with glutathione ethyl ester (10-50 mu M) and cysteamine-HCl (100-500 mu M), to antagonize the effects elicited by glutamate (500 mu M). Alterations of cell redox status were reduced, in a dose-dependent way, by antioxidants; in particular 80 mu M IRFI 016 and 10 mu M genistein almost completely restored glutathione basal levels and significantly diminished ROS production, as well as 100 mu M glutathione ethyl ester These antioxidant effects were stronger than those caused by 500 mu M cysteamine-HCl. Further, glutamate promoted the up-regulation of p50 and p65 NF-kappa B subunits and their nuclear translocation, as revealed by Western blot analysis and electrophoretic mobility shift assay of both subunits. The activation of p50 and p65 NF-kappa B subunits induced by glutamate exposure was significantly reduced by IRFI 016, acting in a dose-dependent manner Altogether these data confirm that the NF-kappa B pathway is involved in cell response to oxidative stress induced by glutamate injury in primary astrocyte cultures, and suggest that the use of antioxidants, such as IRFI 016, may be a helpful pharmacological strategy for neuroprotection